RLMD · Relmada Therapeutics, Inc.

$4.37 -0.17 (-3.74%)

Market Cap

$475.75M

106.67M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
8-K	2026-07-28	—
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-05-28	2026-05-27
10-Q	2026-05-12	2026-03-31
8-K	2026-05-12	—
DEF 14A	2026-04-17	2026-05-27
8-K	2026-03-20	2026-03-19
10-K	2026-03-19	2025-12-31
8-K	2026-03-09	—
8-K	2025-12-15	2025-12-12
8-K	2025-11-13	—
10-Q	2025-11-13	2025-09-30
8-K	2025-11-05	2025-11-04
8-K	2025-11-04	—
8-K	2025-09-17	—
8-K	2025-09-16	2025-09-15
8-K	2025-09-10	—
8-K	2025-09-02	2025-08-29
8-K	2025-08-07	—
10-Q	2025-08-07	2025-06-30
8-K	2025-07-23	2025-07-22
8-K	2025-07-10	2025-07-07
8-K	2025-06-18	2025-06-17
8-K	2025-05-27	2025-05-23
10-Q	2025-05-12	2025-03-31
8-K	2025-05-12	2025-05-08
8-K	2025-04-28	—
DEF 14A	2025-04-11	2025-05-23
8-K	2025-03-27	—
10-K	2025-03-27	2024-12-31
8-K	2025-03-26	2025-03-24
8-K	2025-02-06	2025-02-03
8-K	2025-01-27	2025-01-21
8-K	2025-01-06	2025-01-01
8-K	2024-12-09	—
8-K	2024-12-04	—
10-Q	2024-11-07	2024-09-30
10-Q	2024-08-07	2024-06-30
8-K	2024-05-30	2024-05-24
10-Q	2024-05-08	2024-03-31
DEF 14A	2024-04-09	2024-05-24
8-K	2024-03-19	—
10-K	2024-03-19	2023-12-31
8-K	2024-01-11	2024-01-05
8-K	2024-01-04	—
8-K	2024-01-03	—
10-Q	2023-11-08	2023-09-30
8-K	2023-11-08	—

Showing 1–50 of 119 filings

Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 111 filings 110 filers Visit website Investor relations